119 related articles for article (PubMed ID: 37125431)
1. Carboplatin-loaded ultradeformable vesicles for the management of endometrial cancer:
Patel C; Shukla T; Thakkar H
Ther Deliv; 2023 Feb; 14(2):105-119. PubMed ID: 37125431
[No Abstract] [Full Text] [Related]
2. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles.
Ascenso A; Salgado A; Euletério C; Praça FG; Bentley MV; Marques HC; Oliveira H; Santos C; Simões S
Eur J Pharm Biopharm; 2014 Sep; 88(1):48-55. PubMed ID: 24854884
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
4. A gamma scintigraphy study to investigate uterine targeting efficiency of raloxifene-loaded liposomes administered intravaginally in New Zealand white female rabbits.
Patel A; Tyagi A; Sharma RK; Thakkar H
Drug Deliv; 2016 Nov; 23(9):3330-3338. PubMed ID: 27072061
[TBL] [Abstract][Full Text] [Related]
5. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
[TBL] [Abstract][Full Text] [Related]
6. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting.
Aboud HM; Hassan AH; Ali AA; Abdel-Razik AH
Drug Deliv; 2018 Nov; 25(1):1328-1339. PubMed ID: 29869515
[TBL] [Abstract][Full Text] [Related]
7. Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting.
Patel A; Dhande R; Thakkar H
J Pharm Pharmacol; 2021 Mar; 73(5):653-663. PubMed ID: 33772288
[TBL] [Abstract][Full Text] [Related]
8. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
9. The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1457-63. PubMed ID: 25953248
[TBL] [Abstract][Full Text] [Related]
10. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of a combined treatment of PI3K/mTOR dual inhibitor LY3023414 and carboplatin on human endometrial carcinoma.
Jia N; Che X; Jiang Y; Zhu M; Yang T; Feng W
Gynecol Oncol; 2021 Sep; 162(3):788-796. PubMed ID: 34183163
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells
Kuittinen T; Rovio P; Staff S; Luukkaala T; Kallioniemi A; Grénman S; Laurila M; Mäenpää J
Anticancer Res; 2017 Dec; 37(12):6575-6581. PubMed ID: 29187432
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
14. Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
Alektiar KM; Makker V; Abu-Rustum NR; Soslow RA; Chi DS; Barakat RR; Aghajanian CA
Gynecol Oncol; 2009 Jan; 112(1):142-5. PubMed ID: 19019418
[TBL] [Abstract][Full Text] [Related]
15. Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation.
Molinaro R; Gagliardi A; Mancuso A; Cosco D; Soliman ME; Casettari L; Paolino D
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31816840
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy.
Abdel-Hafez SM; Hathout RM; Sammour OA
Colloids Surf B Biointerfaces; 2018 Jul; 167():63-72. PubMed ID: 29626721
[TBL] [Abstract][Full Text] [Related]
17. The first uterine pass effect.
De Ziegler D; Bulletti C; De Monstier B; Jääskeläinen AS
Ann N Y Acad Sci; 1997 Sep; 828():291-9. PubMed ID: 9329850
[TBL] [Abstract][Full Text] [Related]
18. Role of carboplatin in endometrial and cervical carcinomas.
Muggia FM; Gill I
Semin Oncol; 1992 Feb; 19(1 Suppl 2):90-3. PubMed ID: 1411632
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery in gynaecology: the first uterine pass effect.
Bulletti C; de Ziegler D; Flamigni C; Giacomucci E; Polli V; Bolelli G; Franceschetti F
Hum Reprod; 1997 May; 12(5):1073-9. PubMed ID: 9194669
[TBL] [Abstract][Full Text] [Related]
20. Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach.
Ascenso A; Cruz M; Euletério C; Carvalho FA; Santos NC; Marques HC; Simões S
J Liposome Res; 2013 Sep; 23(3):211-9. PubMed ID: 23631723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
